Meeting
2021 ASCO Annual Meeting
Combination of quantitative features from H&E biopsies and CT scans predicts response to chemotherapy and overall survival in small cell lung cancer (SCLC).
Authors
Cristian Barrera
Case Western Reserve University, Cleveland, OH
Cristian Barrera , Mohammadhadi Khorrami , Prantesh Jain , Pingfu Fu , Kate Butler , Abdullah Osme , Paula Toro , Vidya Sankar Viswanathan , Satyapal Chahar , Afshin Dowlati , Anant Madabhushi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 8572)
DOI
10.1200/JCO.2021.39.15_suppl.8572
Abstract #
8572
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Carboplatin versus cisplatin for the treatment of extensive-stage small cell lung cancer (SCLC): A National VA Database analysis.
First Author: Ibrahim Azar
Poster
2018 Gastrointestinal Cancers Symposium
Epidemiology and treatment of high-grade gastrointestinal neuroendocrine tumors (HG-GI-NETs).
First Author: Olatunji B. Alese
Poster
2015 ASCO Annual Meeting
Survival impact of switching to different topoisomerase I or II inhibitors-based regimens (topo-I or topo-II) in extensive-disease small cell lung cancer (ED-SCLC): supplemental analysis from JCOG0509.
First Author: Shogo Nomura
Poster
2014 ASCO Annual Meeting
Clinical outcomes of patients with recurrent small cell lung cancer receiving third-line chemotherapy.
First Author: Koichi Saruwatari